Skip to main content

Goat F(ab')2 anti-Human IgA Heavy Chain Secondary Antibody [FITC]

Novus Biologicals, part of Bio-Techne | Catalog # NBP1-74919

Novus Biologicals, part of Bio-Techne

Key Product Details

Species Reactivity

Human

Applications

Flow Cytometry, Immunomicroscopy

Label

FITC (Excitation = 495 nm, Emission = 519 nm)

Antibody Source

Polyclonal Goat IgG

Concentration

1.5 mg/ml

Product Specifications

Immunogen

Purified human IgA, (Alpha chain)

Reactivity Notes

Based on IEP, no reactivity is observed to non-immunoglobulin human serum immunoglobulins and light chains on all human immunoglobulins

Specificity

Based on IEP, this antibody reacts with heavy alpha chains on human IgA

Clonality

Polyclonal

Host

Goat

Isotype

IgG

Description

Purity > 90% based on SDS-PAGE Small amounts of intact IgG may be present. . Goat serum was obtained from healthy animals of US origin and under the care of a registered veterinarian.

Applications for Goat F(ab')2 anti-Human IgA Heavy Chain Secondary Antibody [FITC]

Application
Recommended Usage

Flow Cytometry

1:20-1:2000

Immunomicroscopy

1:20-1:2000
Application Notes
This conjugate is suitable for immunomicroscopy and flow cytometry.

Formulation, Preparation, and Storage

Purification

Affinity purified

Formulation

10 mM Sodium Phosphate, 0.15 M Sodium Chloride, pH 7.2, 1 % (w/v) BSA, Protease/IgG free

Preservative

0.05% Sodium Azide

Concentration

1.5 mg/ml

Shipping

The product is shipped with polar packs. Upon receipt, store it immediately at the temperature recommended below.

Stability & Storage

Store at 4C. Do not freeze.

Product Documents

Certificate of Analysis

To download a Certificate of Analysis, please enter a lot number in the search box below.

Product Specific Notices for Goat F(ab')2 anti-Human IgA Heavy Chain Secondary Antibody [FITC]

This product is for research use only and is not approved for use in humans or in clinical diagnosis. Secondary Antibodies are guaranteed for 1 year from date of receipt.

Loading...
Loading...
Loading...
Loading...
Loading...
Loading...